DK1208095T3 - Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetes - Google Patents
Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetesInfo
- Publication number
- DK1208095T3 DK1208095T3 DK00959835T DK00959835T DK1208095T3 DK 1208095 T3 DK1208095 T3 DK 1208095T3 DK 00959835 T DK00959835 T DK 00959835T DK 00959835 T DK00959835 T DK 00959835T DK 1208095 T3 DK1208095 T3 DK 1208095T3
- Authority
- DK
- Denmark
- Prior art keywords
- dibenzopyrans
- diabetes
- treatment
- receptor antagonists
- glucocorticoid receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38825199A | 1999-09-01 | 1999-09-01 | |
PCT/US2000/024234 WO2001016128A1 (en) | 1999-09-01 | 2000-09-01 | Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1208095T3 true DK1208095T3 (da) | 2004-09-20 |
Family
ID=23533319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00959835T DK1208095T3 (da) | 1999-09-01 | 2000-09-01 | Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetes |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1208095B1 (da) |
JP (1) | JP2003508393A (da) |
AR (1) | AR034096A1 (da) |
AT (1) | ATE266655T1 (da) |
AU (1) | AU7109000A (da) |
BR (1) | BR0009320A (da) |
CA (1) | CA2381239A1 (da) |
CO (1) | CO5180649A1 (da) |
DE (1) | DE60010722T2 (da) |
DK (1) | DK1208095T3 (da) |
ES (1) | ES2220529T3 (da) |
HK (1) | HK1047580B (da) |
MX (1) | MXPA02002110A (da) |
PT (1) | PT1208095E (da) |
WO (1) | WO2001016128A1 (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593480B2 (en) * | 1999-09-01 | 2003-07-15 | Abbott Laboratories | Glucocorticoid receptor antagonists for treatment of diabetes |
US7235662B2 (en) | 2003-06-11 | 2007-06-26 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
GB0316290D0 (en) | 2003-07-11 | 2003-08-13 | Glaxo Group Ltd | Novel compounds |
AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
EP1841780B1 (en) | 2005-01-10 | 2011-07-27 | Glaxo Group Limited | Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
PE20061351A1 (es) | 2005-03-25 | 2007-01-14 | Glaxo Group Ltd | COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38 |
TW200724142A (en) | 2005-03-25 | 2007-07-01 | Glaxo Group Ltd | Novel compounds |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
TW200730498A (en) | 2005-12-20 | 2007-08-16 | Glaxo Group Ltd | Compounds |
AU2007242851A1 (en) | 2006-04-20 | 2007-11-01 | Glaxo Group Limited | Novel compounds |
GB0611587D0 (en) | 2006-06-12 | 2006-07-19 | Glaxo Group Ltd | Novel compounds |
TW200820977A (en) | 2006-08-08 | 2008-05-16 | Organon Nv | Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
KR20160129109A (ko) | 2008-05-23 | 2016-11-08 | 아미라 파마슈티칼스 인코포레이티드 | 5-리폭시게나아제 활성화 단백질 억제제 |
US8163743B2 (en) | 2008-06-05 | 2012-04-24 | GlaxoGroupLimited | 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases |
US8765743B2 (en) | 2008-06-05 | 2014-07-01 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
US9216221B2 (en) | 2008-11-07 | 2015-12-22 | University Of Sheffield | Medicament and method of diagnosis for treating subclinical Cushing's syndrome |
WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
JP5656880B2 (ja) | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドGlaxo Group Limited | Pi3キナーゼの阻害剤としての4−オキサジアゾール−2−イル−インダゾール |
US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
JP2012520845A (ja) | 2009-03-17 | 2012-09-10 | グラクソ グループ リミテッド | Itk阻害剤として使用されるピリミジン誘導体 |
AU2010226604A1 (en) | 2009-03-19 | 2011-10-13 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of BTB and CNC homology 1, basic leucine zipper transcription factor 1 (Bach 1) gene expression using short interfering nucleic acid (siNA) sequence listing |
EP2408916A2 (en) | 2009-03-19 | 2012-01-25 | Merck Sharp&Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107958A1 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US20120029054A1 (en) | 2009-03-19 | 2012-02-02 | Merck Sharp & Dohme Corp. | RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA) |
US20120004281A1 (en) | 2009-03-27 | 2012-01-05 | Merck Sharp & Dohme Corp | RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
EP2411516A1 (en) | 2009-03-27 | 2012-02-01 | Merck Sharp&Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111490A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
JP2012521763A (ja) | 2009-03-27 | 2012-09-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 低分子干渉核酸(siNA)を用いたシグナル伝達性転写因子1(STAT1)遺伝子発現のRNA干渉媒介性阻害 |
US20120004282A1 (en) | 2009-03-27 | 2012-01-05 | Merck Sharp & Dohme Corp, | RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
US8399436B2 (en) | 2009-04-24 | 2013-03-19 | Glaxo Group Limited | N-pyrazolyl carboxamides as CRAC channel inhibitors |
EP2421834A1 (en) | 2009-04-24 | 2012-02-29 | Glaxo Group Limited | Pyrazole and triazole carboxamides as crac channel inhibitors |
KR101771193B1 (ko) | 2009-04-30 | 2017-09-05 | 글락소 그룹 리미티드 | Pi3키나아제 억제제로서 옥사졸 치환된 인다졸 |
EP2507231A1 (en) | 2009-12-03 | 2012-10-10 | Glaxo Group Limited | Indazole derivatives as pi 3 - kinase inhibitors |
US20120238559A1 (en) | 2009-12-03 | 2012-09-20 | Glaxo Group Limited | Novel compounds |
EP2507223A1 (en) | 2009-12-03 | 2012-10-10 | Glaxo Group Limited | Benzpyrazole derivatives as inhibitors of p13 kinases |
US20120272951A1 (en) | 2009-12-16 | 2012-11-01 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
WO2011110575A1 (en) | 2010-03-11 | 2011-09-15 | Glaxo Group Limited | Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
GB201007203D0 (en) | 2010-04-29 | 2010-06-16 | Glaxo Group Ltd | Novel compounds |
PL2614058T3 (pl) | 2010-09-08 | 2015-12-31 | Glaxosmithkline Ip Dev Ltd | Polimorfy i sole n-[5-[4-(5-{[(2r,6s)-2,6-dimetylo-4-morfolinylo]-metylo}-1,3-oksazol-2-ilo)-1h-indazol-6-ilo]-2-(metyloksy)-3-pirydynylo]metanosulfonamidu |
JP5876051B2 (ja) | 2010-09-08 | 2016-03-02 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体 |
WO2012035055A1 (en) | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
ES2532213T3 (es) | 2010-10-21 | 2015-03-25 | Glaxo Group Limited | Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias |
EP2630127A1 (en) | 2010-10-21 | 2013-08-28 | Glaxo Group Limited | Pyrazole compounds acting against allergic, inflammatory and immune disorders |
GB201018124D0 (en) | 2010-10-27 | 2010-12-08 | Glaxo Group Ltd | Polymorphs and salts |
GB201104153D0 (en) | 2011-03-11 | 2011-04-27 | Glaxo Group Ltd | Novel compounds |
JP2014507458A (ja) | 2011-03-11 | 2014-03-27 | グラクソ グループ リミテッド | Sykインヒビターとしてのピリド[3,4−B]ピラジン誘導体 |
SG11201600028YA (en) | 2013-09-22 | 2016-02-26 | Calitor Sciences Llc | Substituted aminopyrimidine compounds and methods of use |
EP3057588A1 (en) | 2013-10-17 | 2016-08-24 | GlaxoSmithKline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
EP3057587A1 (en) | 2013-10-17 | 2016-08-24 | GlaxoSmithKline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
US9394281B2 (en) | 2014-03-28 | 2016-07-19 | Calitor Sciences, Llc | Substituted heteroaryl compounds and methods of use |
WO2015173701A2 (en) | 2014-05-12 | 2015-11-19 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions for treating infectious diseases |
EP3347097B1 (en) | 2015-09-11 | 2021-02-24 | Sunshine Lake Pharma Co., Ltd. | Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora |
GB201602527D0 (en) | 2016-02-12 | 2016-03-30 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
JP2019524792A (ja) | 2016-08-08 | 2019-09-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 化合物 |
GB201706102D0 (en) | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
GB201712081D0 (en) | 2017-07-27 | 2017-09-13 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
WO2019099311A1 (en) | 2017-11-19 | 2019-05-23 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use |
BR112022019245A2 (pt) | 2020-03-26 | 2022-11-16 | Glaxosmithkline Ip Dev Ltd | Inibidores de catepsina para prevenir ou tratar infecções virais |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2091721B (en) * | 1980-10-20 | 1984-02-15 | Erba Farmitalia | 6-substituted 6h-dibezo(b,d)pyran derivatives and process for their preparation |
BR9907788A (pt) * | 1998-02-13 | 2001-10-30 | Abbott Lab | Agentes antiinflamatórios seletivos paraglicocorticóides |
-
2000
- 2000-08-30 CO CO00065017A patent/CO5180649A1/es not_active Application Discontinuation
- 2000-08-31 AR ARP000104550A patent/AR034096A1/es not_active Application Discontinuation
- 2000-09-01 JP JP2001519695A patent/JP2003508393A/ja not_active Withdrawn
- 2000-09-01 DE DE60010722T patent/DE60010722T2/de not_active Expired - Lifetime
- 2000-09-01 AU AU71090/00A patent/AU7109000A/en not_active Abandoned
- 2000-09-01 DK DK00959835T patent/DK1208095T3/da active
- 2000-09-01 CA CA002381239A patent/CA2381239A1/en not_active Abandoned
- 2000-09-01 ES ES00959835T patent/ES2220529T3/es not_active Expired - Lifetime
- 2000-09-01 EP EP00959835A patent/EP1208095B1/en not_active Expired - Lifetime
- 2000-09-01 PT PT00959835T patent/PT1208095E/pt unknown
- 2000-09-01 AT AT00959835T patent/ATE266655T1/de not_active IP Right Cessation
- 2000-09-01 MX MXPA02002110A patent/MXPA02002110A/es not_active Application Discontinuation
- 2000-09-01 BR BR0009320-3A patent/BR0009320A/pt not_active IP Right Cessation
- 2000-09-01 WO PCT/US2000/024234 patent/WO2001016128A1/en active IP Right Grant
-
2002
- 2002-10-17 HK HK02107584.5A patent/HK1047580B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0009320A (pt) | 2002-02-05 |
AR034096A1 (es) | 2004-02-04 |
DE60010722T2 (de) | 2005-05-12 |
MXPA02002110A (es) | 2002-11-07 |
CA2381239A1 (en) | 2001-03-08 |
JP2003508393A (ja) | 2003-03-04 |
ATE266655T1 (de) | 2004-05-15 |
CO5180649A1 (es) | 2002-07-30 |
HK1047580A1 (en) | 2003-02-28 |
DE60010722D1 (de) | 2004-06-17 |
PT1208095E (pt) | 2004-09-30 |
AU7109000A (en) | 2001-03-26 |
ES2220529T3 (es) | 2004-12-16 |
WO2001016128A1 (en) | 2001-03-08 |
HK1047580B (zh) | 2005-04-01 |
EP1208095A1 (en) | 2002-05-29 |
EP1208095B1 (en) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1208095T3 (da) | Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetes | |
DK1521733T3 (da) | Modulatorer af glucocorticoid receptoren | |
NO20034122L (no) | Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte | |
DK1339678T3 (da) | Selektive agonister til EP4-receptor til behandling af osteoporose | |
DK1221952T3 (da) | Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidler | |
NO20015272D0 (no) | Glukokortikoid reseptor modulatorer | |
DK1093370T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
IS7324A (is) | Samrunnin heterósýklísk sukkínímíð efnasambönd oghliðstæður þeirra, stillar fyrir starfsemi kjarnahormónaviðtaka | |
ATE416168T1 (de) | Modulatoren des vanilloidrezeptors | |
DK1173431T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1551860T3 (da) | Glukokortikoid-receptorligander til behandling af stofskifteforstyrrelser | |
DK1105382T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1159274T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1200073T3 (da) | Selektive iGluR5-receptorantagonister til behandling af migræne | |
DK1201655T3 (da) | Fremgangsmåde til fremstilling af non-steroide glucocorticoidreceptormodulatorer | |
NO20020574D0 (no) | Substituerte 1,5-dihydropyrrol-2-onderivater som er virksomme som NMDA-reseptorantagonister for behandlingen av smertetilstanden | |
AU2003256922A8 (en) | Substituted heterocyclic compounds as modulators of the ccr5 receptor | |
NO20002036L (no) | Cyklopentenderivater anvendbare som antagonister for motilinreseptoren | |
NO20044373L (no) | Azetidinderivater som CCR-3-reseptorantagonister | |
NO20014356D0 (no) | Bifenylderivater som antagonister av neurokinin-1 reseptoren | |
DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
DK1519936T3 (da) | Fremgangsmåde til fremstilling af nevirapin | |
DK1148874T3 (da) | Anvendelse af antikonvulsive derivater til behandling af bulimia nervosa |